Chair Innovation Task Force
European Medicines Agency, Netherlands
Falk Ehmann is currently working at the European Medicines Agency (EMA) in the Regulatory Science and Innovation Task Force. His main responsibilities include managing and chairing the Innovation Task Force promoting Innovation and novel methodologies in drug development with focus in the areas of Pharmacogenomics (Clinical Pharmacology), Nanomedicines, Borderline and Combined Medicinal Products, and other -omics especially in connection with Personalized Medicine.
Further areas of expertise include leading policy development of Similar Biological Medicinal Products (Biosimilars) with focus on monoclonal antibodies and Vaccines.
He held various positions and responsibilities at the EMA since 2004, including manager of Scientific Advice teams during product development and working as Product Team Leader in the Oncology and Anti-Invectives therapeutic areas of the EMA Unit for Human Medicines Development and Evaluation.
As part of engagement in Pharmacoeconomics, Health Care Market Place and Early Drug Development with King’s College Falk created a cost-benefit decision model, designed protocols for First in Man clinical studies and proposed a definition for Innovation in Health Care in order to value it, which has been shared with the National Institute for Health and Care Excellence (NICE) and the UK ministry of Health.
Prior to joining the EMA Dr Ehmann studied European and International law at the University Berlin, worked as Public Health Researcher at the Robert Koch Institute, at the Representation of the European Commission in Berlin and as Medical Intern at different University Hospitals.
Falk Ehmann wrote his PhD thesis on Molecular Intra Cellular Cell Signalling at the Institute of Biochemistry and Molecular Biology at the University Hospital Hamburg-Eppendorf. His Master Thesis discusses coping mechanisms and responses of European Health Care Systems to the 2009 H1N1v Influenza Pandemic.
Dr Ehmann published more than 30 articles in peer reviewed Journals.
Disclosure information not submitted.
Conversations That Matter: Interactions with Health Authorities
Friday, May 12, 2023
08:45 – 10:00 CEST